Valuation Cipher Pharmaceuticals Inc.

Stocks

Market Closed - Toronto S.E. 21:00:00 16/10/2026 BST			5-day change	1st Jan Change
13.25 ^CAD	-2.07%		-2.93%	-12.02%

09-21	Cipher Pharmaceuticals Inc. Announces Appointment of Rajiv De Silva to Board of Directors, Effective September 21, 2026	CI
09-01	Cipher Pharmaceuticals' Ownership Of Certain Abscoria-Related Clinical Data Affirmed by US Court	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	46.45	96.48	133.1	366.4	382.2	336.7	-	-
Change	-	107.72%	37.94%	175.35%	4.29%	-11.89%	-	-
Enterprise Value (EV)	46.45	96.48	133.1	366.4	382.2	336.7	336.7	336.7
Change	-	107.72%	37.94%	175.35%	4.29%	-11.89%	0%	0%
P/E	4.83x	2.71x	5.12x	21.8x	10.5x	11.8x	10.9x	10.5x
PBR	0.93x	1.11x	1.29x	2.47x	2.23x	1.65x	1.41x	1.23x
PEG	-	0x	-0.2x	-0.6x	0x	-0.6x	1.36x	2.98x
Capitalization / Revenue	1.67x	3.39x	4.65x	7.68x	5.56x	4.75x	4.14x	3.93x
EV / Revenue	0x	0x	0x	0x	0x	4.75x	4.14x	3.93x
EV / EBITDA	0x	0x	0x	0x	0x	8.16x	6.95x	6.42x
EV / EBIT	-	-	-	-	-	-	-	-
EV / FCF	-	-	-	-	0x	9.23x	-	-
FCF Yield	-	-	-	-	10.6%	10.8%	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3666	1.417	1.081	0.658	1.43	1.124	1.214	1.256
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	27.74	28.43	28.6	47.72	68.73	70.85	81.35	85.63
EBITDA ¹	17.59	17.11	17.19	22.43	38.22	41.25	48.49	52.44
EBIT	-	-	-	-	-	-	-	-
Net income ¹	9.807	36.63	27.55	16.51	37.23	27.7	31.76	32.77
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	1.77	3.84	5.54	14.32	15.06	13.25	13.25	13.25
Nbr of stocks (in thousands)	26,241	25,124	24,022	25,590	25,377	25,415	-	-
Announcement Date	17/03/22	16/03/23	14/03/24	18/03/25	12/03/26	-	-	-

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CIPHER PHARMACEUTICALS INC.	11.79x	-	-	-	238M
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	27.33x	6.95x	18.39x	2.15%	394.11B
Weighted average by Cap.	34.72x	8.20x	20.04x	1.84%